Primary Site >> Esophagus Cancer
Gene >> PPARG
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest. PMID: 15274302 |
Ref: Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties. PMID: 16805824 |
Ref: Small molecule agonists of PPAR-gamma exert therapeutic effects in esophageal cancer. PMID: 24272485 |
Ref: A germline predictive signature of response to platinum chemotherapy in esophageal cancer. PMID: 26772957 Ref: Activation of PPARgamma suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway. PMID: 27323819 Ref: Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation. PMID: 27385003 |
Ref: PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis. PMID: 29254243 |
Ref: Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3. PMID: 30214307 |